PACOR, SABRINA
 Distribuzione geografica
Continente #
NA - Nord America 8.807
EU - Europa 6.028
AS - Asia 1.480
SA - Sud America 32
AF - Africa 22
OC - Oceania 12
Continente sconosciuto - Info sul continente non disponibili 11
Totale 16.392
Nazione #
US - Stati Uniti d'America 8.773
PL - Polonia 1.658
SE - Svezia 953
IT - Italia 774
DE - Germania 753
UA - Ucraina 702
CN - Cina 546
SG - Singapore 403
FI - Finlandia 228
GB - Regno Unito 221
HK - Hong Kong 221
TR - Turchia 207
RU - Federazione Russa 188
BG - Bulgaria 125
IE - Irlanda 118
FR - Francia 64
BE - Belgio 50
CH - Svizzera 50
BY - Bielorussia 42
CA - Canada 26
VN - Vietnam 25
NL - Olanda 21
BR - Brasile 20
KR - Corea 15
SN - Senegal 15
BA - Bosnia-Erzegovina 13
AT - Austria 12
IN - India 11
RO - Romania 11
PK - Pakistan 10
CZ - Repubblica Ceca 9
AU - Australia 8
EU - Europa 8
JP - Giappone 8
PT - Portogallo 8
HR - Croazia 7
ID - Indonesia 7
RS - Serbia 7
IR - Iran 6
MX - Messico 5
MY - Malesia 4
NZ - Nuova Zelanda 4
A2 - ???statistics.table.value.countryCode.A2??? 3
AR - Argentina 3
EC - Ecuador 3
HU - Ungheria 3
SI - Slovenia 3
TH - Thailandia 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
CL - Cile 2
DK - Danimarca 2
EG - Egitto 2
ES - Italia 2
GE - Georgia 2
LB - Libano 2
NO - Norvegia 2
PE - Perù 2
PH - Filippine 2
BZ - Belize 1
CM - Camerun 1
CO - Colombia 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
HN - Honduras 1
IL - Israele 1
IQ - Iraq 1
KG - Kirghizistan 1
MA - Marocco 1
MD - Moldavia 1
SD - Sudan 1
SK - Slovacchia (Repubblica Slovacca) 1
TG - Togo 1
VE - Venezuela 1
Totale 16.392
Città #
Warsaw 1.652
Ann Arbor 1.188
Woodbridge 1.067
Fairfield 856
Houston 852
Chandler 700
Jacksonville 618
Ashburn 520
Wilmington 458
Seattle 359
Singapore 337
Cambridge 281
Trieste 270
Princeton 229
Boardman 226
Hong Kong 221
Izmir 194
Beijing 161
Columbus 132
Sofia 125
Dearborn 120
Dublin 116
San Diego 57
Brussels 45
Milan 43
Bern 37
Düsseldorf 37
Santa Clara 35
Falls Church 33
Chicago 26
Bremen 25
Guangzhou 25
Mestre 25
Redwood City 25
Shanghai 23
Buffalo 22
Norwalk 21
Helsinki 20
Kunming 20
Des Moines 19
Hefei 19
Nanjing 19
Verona 19
Dong Ket 18
Los Angeles 17
Sacile 17
Grafing 16
Phoenix 16
Dakar 15
Jinan 15
Ottawa 14
Redmond 14
Sarajevo 13
Amsterdam 12
Seoul 12
Shenyang 12
Washington 12
Dallas 11
Kocaeli 11
São Paulo 11
Vienna 11
Manzano 10
Auburn Hills 9
Munich 9
New York 8
Rivalta 8
Udine 8
Andover 7
Chengdu 7
Hanoi 7
Nanchang 7
Rome 7
Tokyo 7
Toronto 7
Bologna 6
Brno 6
Fuzhou 6
Hebei 6
Múggia 6
Fano 5
Fremont 5
Hangzhou 5
Padova 5
Palermo 5
San Jose 5
Taunsa 5
West Jordan 5
Baotou 4
Camerino 4
Changsha 4
Cividale del Friuli 4
Dongguan 4
Lappeenranta 4
Leipzig 4
Lisbon 4
Pantelimon 4
Stockholm 4
Taiyuan 4
Bahawalpur 3
Baton Rouge 3
Totale 11.745
Nome #
Biofilms from Klebsiella pneumoniae: Matrix Polysaccharide Structure and Interactions with Antimicrobial Peptides 428
Effects of Two Fullerene Derivatives on Monocytes and Macrophages 403
Arabica coffee extract shows antibacterial activity against Staphylococcus epidermidis and Enterococcus faecalis and low toxicity towards a human cell line 381
Effects of gold nanoparticles, protected by self-assembling mixtures of ligands, on eukaryotic cells and model membranes 353
HIV Protease Inhibitors Apoptotic Effect in SH-SY5Y Neuronal Cell Line 327
New aspects of the structure and mode of action of the human cathelicidin LL-37 revealed by the intrinsic probe p-cyanophenylalanine 317
Gold nanoparticles with patterned surface monolayers for nanomedicine: current perspectives 287
Insights on the morphology and biological activity of gold nanoparticles protected by self-assembling mixtures of ligands 282
D-BMAP18 antimicrobial peptide is active In Vitro, resists to pulmonary proteases but loses its activity in a murine model of Pseudomonas aeruginosa lung infection 269
Membrane-active antimicrobial peptide identified in Rana arvalis by targeted DNA sequencing 257
Role of the Escherichia coli SbmA in the antimicrobial activity of proline-rich peptides. 238
Evolution of the primate cathelicidin. Correlation between structural variations and antimicrobial activity. 198
Analysis of the cytotoxicity of synthetic antimicrobial peptides on mouse leucocytes: implications for systemic use. 188
Mixed Fluorinated/Hydrogenated Self-Assembled Monolayer-Protected Gold Nanoparticles: In Silico and In Vitro Behavior 183
The marine toxin palytoxin induces necrotic death in HaCaT cells through a rapid mitochondrial damage 182
The antimetastatic drug NAMI-A potentiates the phenylephrine-induced contraction of aortic smooth muscle cells and induces a transient increase in systolic blood pressure 181
Apoptotic pathways of U937 leukemic monocytes investigated by infrared microspectroscopy and flow cytometry 180
Response of MCa mammary carcinoma to cisplatin and to Na[trans-RuCl4(DMSO)(Im)]. 178
Efficacy of 5-FU combined to Na[trans-RuCl4(DMSO)(Im)], a novel selective antimetastatic agent, on the survival time of mice with P388 leukemia, P388/DDP subline and MCa mammary carcinoma 168
Native oligomerization determines the mode of action and biological activities of human cathelicidin LL-37 168
trans-Ru(II)dimethylsulfoxides: antineoplastic action on mouse tumors 165
Optimization of microfluidic systems for IRMS long term measurement of living cells 165
Rapid and reliable detection of antimicrobial peptide penetration into Gram-negative bacteria based on fluorescence quenching. 164
Cellular Internalization and Cytotoxicity of the Antimicrobial Proline-rich Peptide Bac7(1-35) in Monocytes/Macrophages, and its Activity Against Phagocytosed Salmonella Typhimurium 163
Tumor inhibition and effects on host survival time by rutheniumIII andrhodiumIII complexes with dimethylsulphoxide ligands. 162
Ruthenium(III) complexes as antineoplastic agents. 161
Antifungal Activity of Amphotericin BConjugated to Carbon Nanotubes 160
Chemical, biological and antitumor properties of ruthenium(II) complexes with dimethylsulfoxide 160
Antitumor action of mer-trichlorobis(dimethyl sulfoxide)aminoruthenium(III) (BBR2382) in mice bearing Lewis lung carcinoma 159
Infrared microspectroscopy of live cells in microfluidic devices (MD-IRMS): Toward a powerful label-free cell-based assay 159
Synthetic antimicrobial peptides designed from sequence templates 157
Photobiomodulation therapy promotes in vitro wound healing in nicastrin KO HaCaT cells 156
Structure dependence of biological activities for primate cathelicidins. 155
Effect of targeted minimal sequence variations on the structure and biological activities of the human cathelicidin LL-37 155
Multivalent, mixed self-assembled monolayer protected gold nanoparticles: from design to biological application 154
Dual mode of action of Bac7, a proline-rich antibacterial peptide 153
Primate cathelicidin orthologues display different structures and membrane interactions 149
The human cathelicidin LL-37 - A pore-forming antibacterial peptide and host-cell modulator 149
Na[trans-RuCl4(DMSO)(Im)]*2DMSO - antimetastatic ruthenium agent 148
Fungicidal activity of five cathelicidin peptides against clinically isolated yeasts 147
Primate beta-defensins--structure, function and evolution. 145
Effects of trans-RuCl2 (DMSO)4 on B16 melanoma in mice. 144
Mast cell activation by myelin through scavenger receptor. 144
The development of tumor-inhibiting ruthenium dimethylsulfoxide complexes 144
Synchrotron radiation infrared microspectroscopy of single living cells in microfluidic devices: Advantages, disadvantages and future perspectives 144
Identification and functional characterization of the astacidin family of proline-rich host defence peptides (PcAst) from the red swamp crayfish (Procambarus clarkii, Girard 1852) 143
Antitumor properties of ruthenium(II)-dimethylsulfoxide complexes in the Lewis lung carcinoma system 142
Effects of ruthenium complexes on experimental tumors: irrelevance of cytotoxicity for metastasis inhibition 140
COMPLESSI DI Ru(III) COME AGENTI ANTINEOPLASTICI 139
Na[trans-RuCl4(DMSO)Im], a metal complex of ruthenium with antimetastatic properties 139
Effects of endotoxin in mice bearing solid metastasizing tumors and treated with lysozyme hydrochloride 139
Lysozyme induced recovery of the response to ConA on mononuclear cells harvested from mice bearing MCa mammary carcinoma 137
Effects of L-(adamant-2-yl)glycyl-L-alanyl-D-isoglutamine on the antitumor action of cyclophosphamide, 5-FU, cisplatin and dacarbazine on advanced carcinomas of the mouse 134
Tumour metastatic potential after treatment with selective antimetastatic drugs 133
Antineoplastic effects of mer-RuCl3(DMSO)2(NH3) against murine tumors: comparison with cisplatin and with ImH[RuIm2Cl4]. 129
Study of a potential drug delivery system based on carbon nanoparticles: Effects of fullerene derivatives in MCF7 mammary carcinoma cells 128
Profiling the molecular mechanism of fullerene cytotoxicity on tumor cells by RNA-seq 126
Recovery of lymphocyte CD4+:CD8+ ratio in patients treated with lysozyme 125
Antimetastatic Action and Lymphocyte Activation by the Modified Lysozyme Lyso-M-PEG in Mice with Mca Mammary Carcinoma 125
Computational and experimental investigation on the morphology and biological activity of gold nanoparticles protected by self-assembling mixtures of ligands 122
Antitumour properties of dimethylsulphoxide ruthenium (II) complexes in theLewis lung carcinoma system. 120
null 120
null 120
Fabrication of a microfluidic platform for investigating dynamic biochemical processes in living samples by FTIR microspectroscopy 120
Mechanism of tumor inhibition by the metal complex trans-RuCl2(dimethylsulphoxide)4 120
Features and full reversibility of the renal toxicity of the ruthenium-based drug NAMI-A in mice 120
Controlled alteration of the shape and conformational stability of alpha-helical cell-lytic peptides: effect on mode of action and cell specificity 118
Stimulation of GALT and Activation of Mesenteric Lymphonode Lymphocytes by a Modifìed Iysozyme in CBA Mice with Mca mammary carcinoma 116
Galectin-1 in cartilage: expression and influence on chondrocytes growth and interaction with ECM components 116
Antineoplastic action of p-(3-methyl-1-triazeno)benzoic acid potassium salt, a monomethyl derivative of the antimetastatic compound DM-COOK 116
Antimetastatic action and toxicity on healthy tissues ofNa[trans-RuCl4(DMSO)Im] in the mouse. 115
Bacillus cereus cell and spore properties as influenced by the micro-structure of the medium 115
Modification of growth of MCa mammary carcinoma of CBA mouse by new adamantylpeptides 115
Biological and technological evaluation of PVC containers for human blood and blood components 114
Infrared microspectroscopy of biochemical response of living cells in microfabricated devices 114
The hydrolysis of the anti-cancer ruthenium complex NAMI-A affects its DNA binding and antimetastatic activity: an NMR evaluation. 112
DON'T JUDGE A BOOK BY ITS COVER: JANUS AND STRIPED SAM-PROTECTED GOLD NANOPARTICLES AT THE NANO-BIO INTERFACE 112
Effects on APC antigen presenting cells of short-term interaction with the human human host defense peptide beta-defensin 2 110
Antimetastatic action and toxicity on healty tissues of Na[trans-RuCl4(DMSO)Im] in the mouse. 109
Water soluble ruthenium(III)-dimethyl sulfoxide complexes: chemical behaviour and pharmacological properties 107
Cytofluorimetric analysis of gut-intraepitelial and mesenteric lymph node lymphocytes of tumour bearing mice fed with egg-white lysozyme 106
Antimetastatic action and lymphocyte activation by the modified lysozyme mPEG-Lyso in mice with MCa mammary carcinoma 105
In vitro down regulation of ICAM-1 and E-cadherin and in vivo reduction of lung metastases of TS/A adenocarcinoma by a lysozyme derivative 105
Chemical, biological and antitumor properties of ruthenium-dimethylsulfoxide complexes 104
Structure-activity relationship study on Bac7(1-35), a synthetic fragment of the Pro-rich antibacterial peptide Bac7 103
Effects of two pyridinalalkyliminerhodium(I) complexes in mice bearing MCamammary carcinoma. 103
Effects of the Ru(III) complexes mer-RuCl3(DMSO)2Im and Na[trans-RuCl4(DMSO)Im] on solid mouse tumors. 101
Fragments of the nonlytic proline-rich antimicrobial peptide Bac5 kill Escherichia coli cells by inhibiting protein synthesis 98
Cocultures of metastatic and host immune cells: selective effects of NAMI-A for tumor cells. 97
null 97
Antineoplastic action of egg-white lysozyme on the growth of MCa mammary carcinoma and TLX5 lymphoma in the CBA mouse. 96
Influence of agar content on the growth parameters of Bacillus cereus. 95
Antitumor effect of some rhodium(I) derivatives on MCa mammary carcinoma 95
Inhibition of carrageenin paw edema by pyridinalalkylimine rhodium(I) complexes 93
Cytofluorimetric analysis of gut-intraepithelial and mesenteric lymph nodelymphocytes of tumour bearing mice fed with egg-white lysozyme. 92
Hematologic effects of oral treatment with lysozyme chloride: a phase-II study 92
Observations on the antimetastatic action of lysozyme in mice bearing Lewis lung carcinoma 91
Lysozyme stimulates lymphocyte response to ConA and IL-2 and potentiates 5-fluorouracil action on advanced carcinomas 91
Antineoplastic action of p-(3-methyl-1-triazeno) benzoic acid potassium salt, monomethylderivative of the antimetastatic compound DM-COOK 85
Lysozyme and cancer: role of exogenous lysozyme as anticancer agent (review). 85
Totale 15.274
Categoria #
all - tutte 42.603
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 42.603


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.195 0 0 0 0 227 409 323 347 286 230 245 128
2020/20212.023 215 96 176 300 137 237 139 155 103 210 69 186
2021/20221.673 56 113 123 230 32 137 80 50 172 188 108 384
2022/20232.081 210 287 161 314 188 363 7 179 215 20 78 59
2023/20241.084 97 70 73 71 108 71 163 221 22 29 91 68
2024/2025866 49 117 196 282 222 0 0 0 0 0 0 0
Totale 16.863